{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:31:37Z","timestamp":1768483897797,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00417-022-05563-3","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T08:03:22Z","timestamp":1642579402000},"page":"1823-1835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies"],"prefix":"10.1007","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-4854","authenticated-orcid":false,"given":"Evita Evangelia","family":"Christou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Stavrakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Georgalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Stefaniotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"5563_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","volume":"121","author":"C Pr\u00fcnte","year":"1996","unstructured":"Pr\u00fcnte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26\u201334","journal-title":"Am J Ophthalmol"},{"key":"5563_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","volume":"112","author":"DR Guyer","year":"1994","unstructured":"Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057\u20131062","journal-title":"Arch Ophthalmol"},{"key":"5563_CR3","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1097\/IAE.0000000000001408","volume":"37","author":"L Pertl","year":"2017","unstructured":"Pertl L, Haas A, Hausberger S, Pichler T, Rabensteiner DF, Seidel G, Malle EM, Weger M (2017) Change of choroidal volume in untreated central serous chorioretinopathy. Retina 37:1792\u20131796","journal-title":"Retina"},{"key":"5563_CR4","first-page":"799","volume":"84","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi LA (1986) Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 84:799\u2013845","journal-title":"Trans Am Ophthalmol Soc"},{"key":"5563_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","volume":"139","author":"FC Piccolino","year":"2005","unstructured":"Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87\u201399","journal-title":"Am J Ophthalmol"},{"key":"5563_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","volume":"133","author":"MS Wang","year":"2002","unstructured":"Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133:787\u2013793","journal-title":"Am J Ophthalmol"},{"key":"5563_CR7","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","volume":"103","author":"RF Spaide","year":"1996","unstructured":"Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070\u20132079","journal-title":"Ophthalmology"},{"key":"5563_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0002-9394(14)73524-X","volume":"115","author":"A Scheider","year":"1993","unstructured":"Scheider A, Nasemann JE, Lund OE (1993) Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 115:50\u201356","journal-title":"Am J Ophthalmol"},{"key":"5563_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0161-6420(89)32810-7","volume":"96","author":"R Levine","year":"1989","unstructured":"Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 96:854\u2013859","journal-title":"Ophthalmology"},{"key":"5563_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/bjo.87.6.709","volume":"87","author":"N Kitaya","year":"2003","unstructured":"Kitaya N, Nagaoka T, Hikichi T, Sugawara R, Fukui K, Ishiko S, Yoshida A (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87:709\u2013712","journal-title":"Br J Ophthalmol"},{"key":"5563_CR11","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1167\/iovs.17-21417","volume":"58","author":"M Nicol\u00f2","year":"2017","unstructured":"Nicol\u00f2 M, Rosa R, Musetti D, Musolino M, Saccheggiani M, Traverso CE (2017) Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:2002\u20132010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5563_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/IAE.0000000000001064","volume":"36","author":"SY Chan","year":"2016","unstructured":"Chan SY, Wang Q, Wei WB, Jonas JB (2016) Optical coherence tomographic angiography in central serous chorioretinopathy. Retina 36:2051\u20132058","journal-title":"Retina"},{"key":"5563_CR13","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1167\/iovs.15-17140","volume":"56","author":"MM Teussink","year":"2015","unstructured":"Teussink MM, Breukink MB, van Grinsven MJ, Hoyng CB, Klevering BJ, Boon CJ, de Jong EK, Theelen T (2015) OCT angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci 56:5229\u20135237","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5563_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3928\/23258160-20160324-03","volume":"47","author":"N Feucht","year":"2016","unstructured":"Feucht N, Maier M, Lohmann CP, Reznicek L (2016) OCT Angiography findings in acute central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 47:322\u2013327","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5563_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00417-017-3793-8","volume":"255","author":"S Demirel","year":"2017","unstructured":"Demirel S, Yan\u0131k \u00d6, Nalc\u0131 H, Bat\u0131o\u011flu F, \u00d6zmert E (2017) The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefes Arch Clin Exp Ophthalmol 255:2317\u20132324","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5563_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453\u20131458","journal-title":"Br J Ophthalmol"},{"key":"5563_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ajo.2004.01.043","volume":"137","author":"M Taban","year":"2004","unstructured":"Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073\u20131080","journal-title":"Am J Ophthalmol"},{"key":"5563_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","volume":"33","author":"RM Silva","year":"2013","unstructured":"Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Greg\u00f3rio T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN (2013) Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study. Retina 33:309\u2013315","journal-title":"Retina"},{"key":"5563_CR19","doi-asserted-by":"crossref","unstructured":"Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A (2012) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003. Retina 32 Suppl 1:288\u201398","DOI":"10.1097\/IAE.0b013e31823f99a9"},{"key":"5563_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","volume":"149","author":"M Reibaldi","year":"2010","unstructured":"Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F (2010) Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a non randomized clinical trial. Am J Ophthalmol 149:307-315.e2","journal-title":"Am J Ophthalmol"},{"key":"5563_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2147\/OPTH.S58617","volume":"8","author":"Z Alkin","year":"2014","unstructured":"Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A (2014) Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Clin Ophthalmol 8:685\u2013690","journal-title":"Clin Ophthalmol"},{"key":"5563_CR22","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756\u20131765","journal-title":"Ophthalmology"},{"key":"5563_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","volume":"28","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85\u201393","journal-title":"Retina"},{"key":"5563_CR24","doi-asserted-by":"publisher","first-page":"e0202930","DOI":"10.1371\/journal.pone.0202930","volume":"13","author":"DJ Ma","year":"2018","unstructured":"Ma DJ, Park UC, Kim ET, Yu HG (2018) Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy. PLoS One 13:e0202930","journal-title":"PLoS One"},{"key":"5563_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/eye.2017.290","volume":"32","author":"A Rabiolo","year":"2018","unstructured":"Rabiolo A, Zucchiatti I, Marchese A, Baldin G, Sacconi R, Montorio D, Cicinelli MV, Querques L, Bandello F, Querques G, Medscape (2018) Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy. Eye (Lond) 32:55\u201366","journal-title":"Eye (Lond)"},{"key":"5563_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4274\/tjo.galenos.2018.49035","volume":"49","author":"S G\u00fclka\u015f","year":"2019","unstructured":"G\u00fclka\u015f S, \u015eahin \u00d6 (2019) Current therapeutic approaches to chronic central serous chorioretinopathy. Turk J Ophthalmol 49:30\u201339","journal-title":"Turk J Ophthalmol"},{"key":"5563_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","volume":"37","author":"CK Cheng","year":"2017","unstructured":"Cheng CK, Chang CK, Peng CH (2017) Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy. Retina 37:325\u2013333","journal-title":"Retina"},{"key":"5563_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","volume":"240","author":"U Schl\u00f6tzer-Schrehardt","year":"2002","unstructured":"Schl\u00f6tzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U (2002) Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 240:748\u2013757","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5563_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3928\/23258160-20170329-04","volume":"48","author":"K Fujita","year":"2017","unstructured":"Fujita K, Kawamura A, Yuzawa M (2017) Choriocapillaris changes imaged by OCT angiography after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 48:302\u2013310","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5563_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000456676","volume":"237","author":"Y Xu","year":"2017","unstructured":"Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C (2017) Effect of photodynamic therapy on optical coherence tomography angiography in eyes with chronic central serous chorioretinopathy. Ophthalmologica 237:167\u2013172","journal-title":"Ophthalmologica"},{"key":"5563_CR31","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/ijms18112468","volume":"18","author":"M Nassisi","year":"2017","unstructured":"Nassisi M, Lavia C, Alovisi C, Musso L, Eandi CM (2017) Short-term choriocapillaris changes in patients with central serous chorioretinopathy after half-dose photodynamic therapy. Int J Mol Sci 18:2468","journal-title":"Int J Mol Sci"},{"key":"5563_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pdpdt.2018.01.015","volume":"21","author":"A Demircan","year":"2018","unstructured":"Demircan A, Yesilkaya C, Alkin Z (2018) Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: preliminary results. Photodiagnosis Photodyn Ther 21:375\u2013378","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"5563_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00417-018-04226-6","volume":"257","author":"S Demirel","year":"2019","unstructured":"Demirel S, \u00d6zcan G, Yan\u0131k \u00d6, Bat\u0131o\u011flu F, \u00d6zmert E (2019) Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 257:905\u2013912","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5563_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00417-019-04318-x","volume":"257","author":"SY Chan","year":"2019","unstructured":"Chan SY, Pan CT, Wang Q, Shi XH, Jonas JB, Wei WB (2019) Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 257:1365\u20131372","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5563_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pdpdt.2019.05.041","volume":"27","author":"G Cennamo","year":"2019","unstructured":"Cennamo G, Cennamo M, Caputo G, Mirra F, Pafundi PC, de Crecchio G, Cennamo G (2019) Optical coherence tomography angiography to assess vascular remodeling of the choriocapillaris after low-fluence photodynamic therapy for chronic central serous chorioretinopathy. Photodiagnosis Photodyn Ther 27:162\u2013166","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"5563_CR36","doi-asserted-by":"publisher","first-page":"e0227718","DOI":"10.1371\/journal.pone.0227718","volume":"15","author":"HS Yang","year":"2020","unstructured":"Yang HS, Kang TG, Park H, Heo JS, Park J, Lee KS, Choi S (2020) Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy. PLoS One 15:e0227718","journal-title":"PLoS One"},{"key":"5563_CR37","doi-asserted-by":"publisher","first-page":"101742","DOI":"10.1016\/j.pdpdt.2020.101742","volume":"30","author":"G Cennamo","year":"2020","unstructured":"Cennamo G, Montorio D, Comune C, Clemente L, Iovino C, Carandente R, Tranfa F (2020) Study of vessel density by optical coherence tomography angiography in patients with central serous chorioretinopathy after low-fluence photodynamic therapy. Photodiagnosis Photodyn Ther 30:101742","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"5563_CR38","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/jcm9092734","volume":"9","author":"C Alovisi","year":"2020","unstructured":"Alovisi C, Piccolino FC, Nassisi M, Eandi CM (2020) Choroidal structure after half-dose photodynamic therapy in chronic central serous chorioretinopathy. J Clin Med 9:2734","journal-title":"J Clin Med"},{"key":"5563_CR39","doi-asserted-by":"crossref","unstructured":"Xu F, Zhou L, Lai K, Gong Y, Li L, Lian P, Huang C, Ding X, Lu L, Jin C (2020) Quantitative evaluation of retinal vessel density in central serous chorioretinopathy after half-dose photodynamic therapy. Curr Eye Res","DOI":"10.1080\/02713683.2020.1843684"},{"issue":"Suppl","key":"5563_CR40","first-page":"1","volume":"63","author":"JD Gass","year":"1967","unstructured":"Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl):1\u2013139","journal-title":"Am J Ophthalmol"},{"key":"5563_CR41","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770","journal-title":"Prog Retin Eye Res"},{"key":"5563_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00006982-199911000-00005","volume":"19","author":"T Iida","year":"1999","unstructured":"Iida T, Kishi S, Hagimura N, Shimizu K (1999) Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508\u2013512","journal-title":"Retina"},{"key":"5563_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ophtha.2013.10.014","volume":"121","author":"D Ferrara","year":"2014","unstructured":"Ferrara D, Mohler KJ, Waheed N, Adhi M, Liu JJ, Grulkowski I, Kraus MF, Baumal C, Hornegger J, Fujimoto JG, Duker JS (2014) En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 121:719\u2013726","journal-title":"Ophthalmology"},{"key":"5563_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00006982-199901000-00003","volume":"19","author":"M Uyama","year":"1999","unstructured":"Uyama M, Matsunaga H, Matsubara T, Fukushima I, Takahashi K, Nishimura T (1999) Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy. Retina 19:12\u201321","journal-title":"Retina"},{"key":"5563_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40123-018-0159-1","volume":"8","author":"B Cakir","year":"2019","unstructured":"Cakir B, Reich M, Lang S, B\u00fchler A, Ehlken C, Grundel B, Stech M, Reichl S, Stahl A, B\u00f6hringer D, Agostini H, Lange C (2019) OCT angiography of the choriocapillaris in central serous chorioretinopathy: a quantitative subgroup analysis. Ophthalmol Ther 8:75\u201386","journal-title":"Ophthalmol Ther"},{"key":"5563_CR46","first-page":"835","volume":"120","author":"U Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth U, Laqua H, Schl\u00f6tzer-Schrehard U, Viestenz A, Naumann GO (2002) Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120:835\u2013844","journal-title":"Arch Ophthalmol"},{"key":"5563_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/bjophthalmol-2020-316076","volume":"105","author":"M Ho","year":"2021","unstructured":"Ho M, Lai FHP, Ng DSC, Iu LPL, Chen LJ, Mak ACY, Yip Y, Cheung C, Young AL, Brelen M (2021) Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathyrandomised to micropulse laser or photodynamic therapy. Br J Ophthalmol 105:555\u2013560","journal-title":"Br J Ophthalmol"},{"key":"5563_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajo.2016.07.023","volume":"170","author":"RF Spaide","year":"2016","unstructured":"Spaide RF (2016) Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression. Am J Ophthalmol 170:58\u201367","journal-title":"Am J Ophthalmol"},{"key":"5563_CR49","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1097\/IAE.0000000000000635","volume":"35","author":"MC Savastano","year":"2015","unstructured":"Savastano MC, Lumbroso B, Rispoli M (2015) In vivo characterization of retinal vascularization morphology using optical coherence tomography angiography. Retina 35:2196\u20132203","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05563-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T10:06:24Z","timestamp":1651485984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05563-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05563-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any studies with human participants or animals conducted by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Andreas Katsanos has to report lecture fees and congress expenses by Santen, Vianex, Zwitter, and research grant by Laboratoires Thea. The other authors have no disclosures to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}